CERC-006

Phase 1Small molecule

AAvalo Therapeutics, Inc.

CERC-006 is one of 10 small molecule programs targeting Lymphatic Malformation. It is currently in Phase 1.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Lymphatic MalformationActive, not recruiting

Lymphatic MalformationPhase 1

Active, not recruiting

Competition

Competitive Landscape

16 competitors in Lymphatic Malformation

#DrugCompanyPhaseTrials

Blenoxane

Bristol-Myers Squibb

Phase 2

2 2

Piqray

Novartis

Phase 2

1 3

Viagra

VViatris Specialty LLC

Phase 2

2 4

Rapamune

PPrism Pharmaceuticals

Phase 2

1 5

Vibramycin

PPfizer's Upjohn has merged with Mylan to form Viatris Inc.

Phase 2

1 6

Rapamycin

MMaastricht Radiation Oncology

Phase 2

1 7

TARA-002

PProtara Therapeutics

Phase 2

1 8

PTX-022

PPalvella Therapeutics, Inc.

Phase 2

1 9

Selenium

SSWOG Cancer Research Network

Phase 1

1 10

CERC-006

AAvalo Therapeutics, Inc.

Phase 1

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Lymphatic Malformation1 trial

A Pharmacokinetic, Pharmacodynamic, Safety and Tolerability Study of CERC-006 in Adults With Complex Lymphatic Malformations

Withdrawn·AAvalo Therapeutics, Inc.·Phase 1·NCT04994002

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for CERC-006. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — CERC-006 compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for CERC-006. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Avalo Therapeutics, Inc. company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 1[1]
Company: AAvalo Therapeutics, Inc.

CERC-006

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Lymphatic Malformation1 trial

References

Drug Info

Quick Facts

Related News